Skip to main content
Equibles
UHS logo

UHS · Universal Health Services Inc · Metrics

Track UHS — free

Use UHS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UHS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$187.30 -0.84 (-0.44%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.08B
Shares
58.94M
Volume · Oct 23 222.18K Avg daily vol (3M) 751.18K

UHS metrics

109 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$188.13
Market cap
$11.08B

Price action

20 metrics
Price change (1W)
+0.4%
Price change (30D)
+4.9%
Price change (3M)
+24.4%
Price change (6M)
+3.8%
Price change (YTD)
-13.7%
Price change (1Y)
-10.6%
Trailing year
Price change (5Y)
+38.7%
52-week high
$244.18
52-week low
$141.17
Change from 52-week high
-23.0%
Change from 52-week low
+33.3%
Annualized volatility
32.3%
Annualized volatility (3M)
26.8%
Beta
0.1
RSI (14D)
63.2
Price vs SMA 50
+6.7%
Price vs SMA 200
+5.8%
Avg volume (3M)
751,180
Relative volume
0.7
Average dollar volume
$129.70M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
58.94M

Valuation

12 metrics
P / E (TTM)
7.7
Trailing earnings · reciprocal yield 13.0%
PEG ratio
0.8
EV / revenue
0.9×
reciprocal yield 116.1%
EV / EBITDA
5.8×
reciprocal yield 17.3%
EV / EBIT
7.6×
reciprocal yield 13.2%
P / sales
0.6×
reciprocal yield 166.4%
P / book
1.4
reciprocal yield 69.0%
FCF yield
7.8%
TTM · current market cap
Buyback yield
9.9%
P / FCF
12.9
reciprocal yield 7.8%
P / operating cash flow
6.0
reciprocal yield 16.5%
Earnings yield
14.0%

Historical valuation

8 metrics
P / E historical average (3Y)
11.8×
reciprocal yield 8.5%
P / E historical average (5Y)
12.0×
reciprocal yield 8.3%
EV / revenue historical average (3Y)
1.0×
reciprocal yield 96.4%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 95.6%
EV / EBIT historical average (3Y)
10.6×
reciprocal yield 9.5%
EV / EBIT historical average (5Y)
11.0×
reciprocal yield 9.1%
EV / EBITDA historical average (3Y)
7.6×
reciprocal yield 13.2%
EV / EBITDA historical average (5Y)
7.7×
reciprocal yield 12.9%

Dividends & buybacks

7 metrics
Dividend yield
0.4%
Trailing 12 months
Payout ratio
3.2%
Shareholder yield
10.3%
Dividend / share (TTM)
$0.80
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-09-01

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
—
Operating margin
11.4%
Trailing 12 months
Net margin
8.4%
Gross profit (TTM)
—
Operating profit (TTM)
$2.06B
Net income (TTM)
$1.53B
Trailing 12 months
Diluted EPS (TTM)
$24.50
FCF margin
4.7%
Effective tax rate
23.5%

Per share

11 metrics
Revenue per diluted share (TTM)
$291.90
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$33.16
EBITDA per diluted share (TTM)
$43.49
Net income per diluted share (TTM)
$24.55
Operating cash flow per diluted share (TTM)
$28.99
Free cash flow per diluted share (TTM)
$13.62
Capital expenditures per diluted share (TTM)
$15.37
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.54
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+8.3%
Year over year
Net income growth YoY
+1.5%
Revenue (TTM)
$18.11B
Trailing 12 months
EPS growth YoY
+10.1%
Shares change YoY
-7.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.0%
Revenue CAGR (5Y)
+8.5%
EPS CAGR (3Y)
+36.2%
EPS CAGR (5Y)
+16.0%
FCF CAGR (3Y)
+48.0%
FCF CAGR (5Y)
-12.2%

Quality

14 metrics
Return on equity
20.3%
Return on assets
9.6%
Debt / equity
0.6
Current ratio
1.1
EBITDA (TTM)
$2.70B
Free cash flow (TTM)
$845.40M
Quick ratio
1.1
Interest coverage
13.1
Net debt / EBITDA
1.7
Return on invested capital
12.9%
Trailing 12 months
Net cash
−$4.71B
Latest balance sheet
Cash & equivalents
$138.80M
Total assets
$15.94B
Total debt
$4.85B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.80B
Capital expenditures (TTM)
$954.90M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$95.39M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

9 metrics
13F filers
600
13F filer change QoQ
-58
Institutional ownership
89.4%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+6.9%
Holder tenure
18.0
Price vs estimated holder cost
-18.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.9%

Short interest

3 metrics
Short interest
4.3%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 352915 CUSIP 913903100 13F (30d) 121 filings 111 filers Visit website Investor relations